Serum adipokine profiles in Kawasaki disease

References

• Kawasaki T. Acute febrile mucocutaneous syndrome with lym-phoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178–222.
   PubMedGoogle Scholar
• Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776–80.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yashiro M, Uehara R, Old I, Watanabe M, Ya-nagawa H. Epidemiologic features of Kawasaki disease in Japan: results from the Nationwide Survey in 2005–2006. J Epidemiol. 2008;18: 167–72.
   Google Scholar
• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129–39.
   PubMed Web of Science ®Google Scholar
• Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf). 2006;186:5–16.
   Google Scholar
• Rasouli N, Kern PA. Adipocytokines and the metabolic compli-cations of obesity. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S64–73.
   Google Scholar
• Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001;98:502–6.
   PubMed Web of Science ®Google Scholar
• Degawa-Yamaguchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003;88: 5452–5.
   Google Scholar
• Muredach PR, Michael L, Megan LW, Anand R, Mitcell AL, Daniel JR. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932–9.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Ouchi N, Kihara S, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res. 2004;94:e27–31.
   PubMed Web of Science ®Google Scholar
• Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidi-nedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279:12152–62.
   PubMed Web of Science ®Google Scholar
• Shinha MK, Caro JF. Clinical aspects of leptin. Vitam Horm. 1998;54:1–30.
   PubMed Web of Science ®Google Scholar
• Havel PJ, Kasim-Karakas S, Mueller W, et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996;81: 4406–13.
   PubMed Web of Science ®Google Scholar
• Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–30.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6: 772–83.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Kusunoki N, Tanaka N, et al. Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med. 2011;50:269–75.
   PubMed Web of Science ®Google Scholar
• Nozue H, Imai H, Saitoh H, Aoki T, Ichikawa K, Kamoda T. Serum resistin concentrations in children with Kawasaki disease. Inflamm Res. 2010;59:915–20.
   PubMed Web of Science ®Google Scholar
• Yang RZ, Huang Q, Xu A, et al. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun. 2003;310:927–35.
   PubMed Web of Science ®Google Scholar
• Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300:472–6.
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 1978;61:100–7.
   PubMed Web of Science ®Google Scholar
• Ichiyama T, Yoshitomi T, Nishikawa M, et al. NF-kappaB acti-vation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol. 2001;99:373–7.
   PubMed Web of Science ®Google Scholar
• Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010;14(6B):1419–31.
   Google Scholar
• Wang GB, Li CR, Zu Y, Yuan XW. The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki dis-ease. Zhonghua Er Ke Za Zhi. 2006;44:333-336 (in Chinese).
   Google Scholar
• Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T. Prediction of resistance to intravenous immuno-globulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149:237–40.
   Google Scholar
• Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intrave-nous immunoglobulin unresponsiveness in patients with Kawa-sald disease. Circulation. 2006;113:2606–12.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatremia in Kawasaki disease. Pediatr Nephrol. 2006;21: 778–81.
   PubMed Web of Science ®Google Scholar
• Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease. Acta Paediatr. 2006;95:1312–4.
   Google Scholar
• Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child. 2006;91:847–51.
   PubMed Web of Science ®Google Scholar
• Kitahara K, Kusunoki N, Kakiuchi T, Suguro T, Kawai S. Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun. 2009;378: 218–23.
   Google Scholar
• Kusunoki N, Kitahara K, Kojima F, et al. Adiponectin stimulates prostaglandin E2 production in rheumatoid synovial fibroblasts. Arthritis Rheum. 2010;62:1641–9.
   PubMed Web of Science ®Google Scholar
• Ehling A, Schaffier A, Herfarth H, Tamer IH, Anders S, Distler 0, et al. The potential of adiponectin in driving arthritis. J Immunol. 2006;176:4468–78.
   Google Scholar
• Ozgen M, Koca SS, Aksoy K, Dagli N, Ustundag B, Isik A. Visfatin levels and intima-media thicknesses in rheumatic dis-eases. Clin Rheumatol. 2010 (Epub ahead of print).
   Google Scholar